This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. Even Botox, popular in the modern day for smoothing fine lines and plumping the skin, was first used as a treatment for Parkinson’s.
Pelage Pharmaceuticals has closed a $16.75 million Series A financing led by GV with participation from Main Street Advisors, Visionary Ventures and YK BioVentures to advance a first-in-class treatment for androgenetic alopecia and other types of alopecia including chemotherapy-induced hair loss.
Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. Watch Now: Nanette B. in September 2023.
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”
The Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-Code (J7354) for Verrica’s YCANTH, a molluscum contagiosum treatment. Medicaid and Medicare patient populations,” says Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, in a news release. “In
Children and young adults with eczema or allergies or who have difficulty swallowing may have eosinophilic esophagitis, according to a review study in the Canadian Medical Association Journal (CMAJ). Food and Drug Administration has expanded the indication for dupilumab (Dupixent, Sanofi, Regeneron Pharmaceuticals, Inc.)
Millions of people suffer for years or decades without treatment because insurance companies don’t approve screening for autoimmunity until the patient shows significant signs of organ or tissue destruction. At this point, the patient can be prescribed some type of immune-suppressing treatment. About the Author: Datis Kharrazian, Ph.D.,
There’s a crucial difference between cosmetic retinol use and medicaltreatment with retinoids ; the latter is for specific skin conditions under professional supervision. A dermatologist can provide personalized recommendations and treatment plans tailored to your child’s specific needs.
discussed treatment options, the study showed. featured the pharmaceutical industry. The researchers didn’t analyze gaps in education or melanoma information, but they noted that informational videos directed toward healthcare professionals often used medical terminology that the general population may find difficult.
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.
Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes. Lio, MD Distraction techniques and pharmacologic measures can help keep pediatric patients comfortable during common dermatologic procedures.
Reduced Inflammation : Compounds like oleocanthal mimic anti-inflammatory medications, offering natural pain relief. Current Pharmaceutical Design , 17(8), pp.754768. Anti-inflammatory activity of extra virgin olive oil polyphenols: which role in the prevention and treatment of immune-mediated inflammatory diseases? Russell, A.
Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences in Washington, DC, shares his excitement about chronic spontaneous urticaria (CSU) treatments coming down the pike including remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase inhibitor.
Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Torii) to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH (cantharidin) for the treatment of common warts. With a prevalence of approximately 22 million patients in the U.S.
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed minimal systemic absorption.
By incorporating one microneedling treatment every three months and supporting it with 3 – 4 nano infusion treatments in between, while using topicals with potent ingredients and a proven delivery system professionals provide a comprehensive treatment that delivers visible, long-lasting age management results.
Food and Drug Administration (FDA) has approved Zelsuvmi (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum in adults and children one year of age and older. Zelsuvmi is expected to be commercially available during the second half of 2024, according to Ligand Pharmaceuticals. in September 2023.
Disclaimer: We in no way endorse the Joe Tippens Cancer Protocol as a cure for cancer, and as always, you should consult your physician before starting any new medications or treatment plans. However, it is also being used by humans in a cancer treatment method known as the Joe Tippens Protocol. What Is Fenbendazole?
Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. Both groups had similar proportions of patients with treatment-emergent adverse events (TEAEs).
Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains.
Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains.
The treatment protocol for ALL involved the drug pegaspargase because it is usually successful for a patient like Abby. But today, what scares oncologists is the shortage of highly effective medications. This situation forces doctors to choose less-effective alternatives, delay treatment, or reduce treatment dosages.
Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Similarly, Incyte and AFYX Therapeutics are developing new therapeutics for lichen planus.
One of the key goals for every medical + spa skin care professional is to find procedures, products, and devices that can be used in treatment to improve and correct skin issues. Over the past year, L+A has traveled the globe looking for the most effective treatment options to share with our community. Revision Skincare, M.A.D
Silverberg, MD, Chief of Pediatric Dermatology for the Mount Sinai Health System in New York, reviews the rationale for treating Molluscum Contagiosum and shares updates on available treatments including disruptive techniques and the newly approved Zelsuvmi (berdazimer topical gel, 10.3% (Zelsuvmi, Ligand) cantharidin (Ycanth, Verrica).
Alicia Edwards from Howard University College of Medicine will conduct a remote project titled, “ Investigating the Prevalence of Inborn Errors of Immunity and Treatment Responses in Pediatric Alopecia Areata: A Multi-Site Study ” under the mentorship of Leslie Castelo-Soccio, MD, PhD at National Institutes of Health.
Osmosis uses a unique combination of active ingredients that focuses on three important factors: our pharmaceutical-grade delivery system, because most aging occurs deep within the skin; our patented products that create real changes in the skin; and our unique inside-out approach that triggers collagen/elastin and plumps the volume of the face.
a drug developer working on a treatment similar to Novo’s Wegovy, jumped 12%. better known as Weight Watchers — which bought a telemedicine firm that prescribes obesity medications earlier this year, soared 13%. Makers of syringes for the pharmaceutical industry, Stevanato Group SpA and West Pharmaceutical Services Inc.,
The increasing popularity of weight loss medications like semaglutide and tirzepatide highlights the effectiveness of GLP-1 receptor agonists in helping individuals manage their weight. In clinical trials, medications like semaglutide have shown substantial results. However, as with any medication, there are potential side effects.
Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceuticaltreatments. Physical therapists incorporate pain management strategies like trigger point massages in their treatment routines because they successfully provide patients with pain relief. What is Trigger Point Therapy?
More than 200 residents, medical students and Fellow members have committed to volunteer for MBWS outreach events at universities, hospitals, and community venues, with a planned distribution of 10,000 gift bags with tips for managing winter skin and free moisturizing products generously provided by campaign sponsor, Clinique.
Sun Pharmaceutical Industries, Inc. Food and Drug Administration-approved topical acne treatment available in the U.S. The parents misunderstand this unfamiliar word as inappropriate for family dinner conversation but quickly learn from Dr. Lee that it is a medical term that does not need to be censored.
LEO Pharma recently acquired TMB-001 and other assets from Timber Pharmaceuticals following Timber’s Chapter 11 bankruptcy filing. If and when we receive FDA approval, we will consider this treatment as a potential part of lifestyle management for CI. Will we see a focus on orphan diseases from LEO Pharma?
Consult Healthcare Providers When Necessary : Seek professional advice for persistent, severe, or unusual scalp symptoms to ensure accurate diagnosis and effective treatment. Dandruff (Seborrheic Dermatitis) Dandruff, medically known as seborrheic dermatitis , is a common scalp condition marked by excessive shedding of skin cells.
Dr. Nasha Winters is a naturopathic physician who specializes in cancer treatment. If you’re affected by cancer and believe her skills may be helpful, you can have your clinician consult with her to fine-tune your treatment. They’re markers of how advanced the cancer is and how well you’re doing as you’re progressing through treatment.
Urticaria symptoms clear within minutes after dosing , and neffy could offer patients a novel treatment option to address existing gaps in the efficacy of currently available antihistamines or biologics.” Food and Drug Administration (FDA) opted not to approve neffy for emergency treatments of severe allergic reactions in September 2023.
Verrica Pharmaceuticals Inc.’s s VP-315 is showing promise in the treatment of basal cell carcinoma, according to Part 2 of its Phase 2 clinical trial. The key preliminary Part 2 results were: No dose-limiting toxicities or Treatment-Related Serious Adverse Events were reported.
Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.
“The approval of SIMLANDI marks the first high-concentration, citrate-free biosimilar to Humira with IC status,” says Dr. Eric Hughes, Executive Vice President Global R&D and Chief Medical Officer at Teva, in a news release. where biologics represent well over 40% of all pharmaceutical spending.
Sun Pharmaceutical Industries, Inc. Food and Drug Administration-approved topical acne treatment available in the U.S. Food and Drug Administration-approved topical acne treatment available in the U.S. The new campaign focuses on the role of sebum as a main cause of acne. WINLEVI is the first and only U.S.
Joshua Zeichner, MD, Associate Professor of Dermatology at the Mount Sinai Hospital in New York City, reviews the latest information on prescribing and monitoring isotretinoin for patients with severe nodulocystic acne and provides an update on the potential risks associated with this medication.
2 However, as "modern" medicine and the pharmaceutical industry ramped up the health care machine, vitamin C quickly fell out of favor as it is inexpensive, easy to administer and has very few side effects. In other words, as effective as vitamin C is in prevention and treatment, you can’t make money prescribing or manufacturing it.
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Del Rosso, DO, a dermatologist in Las Vegas, NV, and the new President of the American Acne and Rosacea Society.
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, offers tips on how to mitigate against some of the paraneoplastic and chemotherapy-induced skin issues seen in cancer patients.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content